Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

While anecdotal evidence suggests that select 5-hydroxytryptamine 2A (5-HT(2A)) receptor ligands, including psilocybin, may have long-lasting therapeutic effects after limited dosing in headache disorders, controlled investigations are lacking. In an exploratory double-blind, placebo-controlled, cro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurotherapeutics
Autori principali: Schindler, Emmanuelle A. D., Sewell, R. Andrew, Gottschalk, Christopher H., Luddy, Christina, Flynn, L. Taylor, Lindsey, Hayley, Pittman, Brian P., Cozzi, Nicholas V., D’Souza, Deepak C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8116458/
https://ncbi.nlm.nih.gov/pubmed/33184743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00962-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi